Recipharm will serialize customers' drugs for free until US and EU rules come into force

By Gareth Macdonald

- Last updated on GMT

Recipharm offers free serialization (iStock/3D_generator)
Recipharm offers free serialization (iStock/3D_generator)

Related tags Electric charge

Recipharm has announced it will serialize customers’ products for free until legislation comes into force in key markets.

The Sweden-based contractor said it would spend €40m ($44m) on serialization technology in February​, citing requirements due to come into force in the US next year and Europe in 2019 as the driver for the investment.

Kjell Johansson, Recipharm’s president of manufacturing services in Europe, also cited the rules a a driver for the firm's decision to provide a free-of-charge serialization service.

Serialisation will come into force in the US in 2017 and in Europe in beginning of 2019. It will be a huge challenge for our customers to adopt​” he said, adding that “by being ready now we will be able to support our customers in this process​.”

Recipharm is one of a number of CDMOs that has invested in serialization technology in recent years – Aesica​ and Almac​ being just two examples – and the market is becoming very competitive according to Johnson.

We believe that our offer with no upfront payment, free of charge until the legal requirement comes into force and no volume commitment will be attractive to customers. This combined with a fixed fee for service will make it very simple for our customers​.”

He added that: "Recipharm is prepared to take on the financial burden until legislation comes into force, to support customers to 'become serialized' as soon as possible.​"

No volume commitment 

Pharmaceutical firms that use the service will have to agree to use the paid service when the regulations come into effect. However, they will not be required to make “volume commitments​” Johnson said.

When Recipharm does begin charging, there will be a standard fee that will vary depending on the specific requirements of the project.

We have already started to communicate with our customers what the fee will be for the above services. This fee relates to a ‘standard solution’ compliant with relevant legislation. In addition to this some customers want to have some extras, different printing, labels etc which will build the total fee.

We will disclose the fee for our standard solution as soon as we have communicated this with our current customers​” he said.

Related news

Show more

Related products

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Thermo Fisher Scientific - Process Liquid Preparation Services | 21-Feb-2023 | Technical / White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Enhance your cGMP chemical supply chain

Enhance your cGMP chemical supply chain

Thermo Fisher Scientific – Production Chemicals and Services | 09-Feb-2023 | Technical / White Paper

Supply chain issues have real, quantifiable impacts on biomanufacturers. However, the right support can make a cGMP supply chain operate seamlessly. Thermo...

Related suppliers

Follow us


View more